Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Net Margin (2025)

Historic Net Margin for Coeptis Therapeutics Holdings (COEP) over the last 1 years, with Q3 2025 value amounting to 1220.84%.

  • Coeptis Therapeutics Holdings' Net Margin changed N/A to 1220.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 2727.78%, marking a year-over-year change of. This contributed to the annual value of 17932.37% for FY2021, which is N/A changed from last year.
  • Coeptis Therapeutics Holdings' Net Margin amounted to 1220.84% in Q3 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' Net Margin registered a high of 1220.84% during Q3 2025, and its lowest value of 5440.95% during Q1 2025.